Kid:
Agree on microcaps. High hopes, but don't always work out, which is where DD comes in.
Also of note, the 9 patients in the Phase 2A had mild AD; Phase 2B patients have moderate-to-severe AD, so if Bryostatin works, it's more likely to work in this group of patients.
No guarantees Neurotrope will work out, but I feel much better about continuing to hold, and we can repeat some of the compassionate use outcomes.
Hope to be able to sell a little at higher prices to lower risk...
Good luck
Market Data 
Markets 
AI
